Myriad Genetics (MYGN) Q4 2011 Earnings Call August 09, 2011 4:30 pm ET Executives Peter Meldrum - Chief Executive Officer, President and Director Rebecca Chambers - James Evans - Chief Financial Officer, Principal Accounting Officer and Treasurer Mark Capone - President of Myriad Genetic Laboratories Inc Analysts Scott Gleason - Stephens Inc. Dane Leone - Macquarie Research Charles Duncan - JMP Securities LLC Tycho Peterson - JP Morgan Chase & Co Michael Yee - RBC Capital Markets, LLC Doug Schenkel - Cowen and Company, LLC Unknown Analyst - Jon Wood - Jefferies & Company, Inc. PresentationOperator
Ladies and gentlemen, thank you for standing by, and welcome to the Myriad Genetics 2011 Financial Earnings Conference Call. [Operator Instructions] And as a reminder, this conference is being recorded, Tuesday, August 9, 2011. I would now like to turn the conference over to Rebecca Chambers, Director of Investor Relations. Please go ahead, ma'am. Rebecca Chambers Thank you, Lindsay. Good afternoon, everyone, and welcome to the Myriad Genetics Fourth Quarter and Fiscal Year 2011 Earnings Call. During the call, we will review the financial results we've released today and detail the strategic directives, which will guide the company on fiscal 2012, after which we will host a question-and-answer session. If you had not had a chance to review the earnings release, it can be found in the Investor Relations section of our website at myriad.com. Presenting today will be Pete Meldrum, President and Chief Executive Officer; Mark Capone, President, Myriad Genetic Laboratories; and Jim Evans, Chief Financial Officer. This call can be heard live via webcast along with the slide presentation at myriad.com. The call is being recorded and will be archived along with the presentation in the Investors section of our website.